For more than 30 years, AAIPharma Services has provided drug product development services to pharma, biotech, and medical device companies around the world. Our team of 450 pharmaceutical professionals, scientists and engineers pride themselves on providing solutions to the most difficult drug development and manufacturing challenges. No matter how large or small your company is, we can tailor a program to fit your specific needs. Our customers may choose from specific services--including analytical and formulation services, clinical packaging and distribution, contract manufacturing and oral drug delivery technologies--or a complete product development package to meet their objectives.
AAIPharma Services provides cGMP manufacturing services for clinical and commercial products at its solid dosage and sterile product manufacturing facilities. The facilities located in Charleston, SC (sterile) and Wilmington, NC (solid dose) are comparable in size/staffing and provide flexible capabilities for the processing of a wide range of pharmaceutical drug products, including controlled substances and potent compounds. Clinical manufacturing activity ranges from Phase I through III trials with scale-up and validation support to address commercial launch requirements and to support subsequent commercial supply. Both sites are FDA and MHRA approved and produce products for the US and European markets.